ThrombAssure Enhanced™

CPT: 81240; 81241; 83090; 85300; 85303; 85306; 85598; 85613(x2); 85730; 85732(x2); 86146(x3); 86147(x3) Note: If prolonged, aPTT will reflex to Immediate aPTT Mixing Studies. If the dRVVT screen is normal, the confirmation and ratio will not be performed.

Test Includes

Factor II Gene Mutation (Prothrombin G20210A), Factor V Leiden Mutation, aPTT, Immediate aPTT Mixing Studies, Anticardiolipin Antibody (IgG, IgM, IgA), Antithrombin Activity, dRVVT, Hexagonal Phospholipid Neutralization, Homocysteine, Protein C Activity (Chromogenic), Protein S Antigen Free, Beta-2 Glycoprotein I (IgG, IgA, IgM), Lupus Anticoagulant Interpretation


Special Instructions

Informed consent required for NY patients. If prolonged, aPTT will reflex to Immediate aPTT Mixing Studies. If the dRVVT screen is normal, the confirmation and ratio will not be performed.


Expected Turnaround Time

2 - 7 days


Specimen Requirements


Specimen

Citrated plasma, whole blood, and serum


Volume

Three tubes, 2 mL each, citrated plasma, 5 mL whole blood, and 1 mL serum


Minimum Volume

Three tubes, 1 mL each, citrated plasma,1.5 mL whole blood, and 1 mL serum. (Note: This volume does not allow for repeat testing.)


Container

Citrated plasma: Light blue-top (sodium citrate) tube Whole blood: Lavender-top (EDTA) tube or yellow-top (ACD) tube Serum: Red-top tube


Storage Instructions

Ship plasma and serum frozen on dry ice. Ship whole blood ambient; avoid extreme temperatures.


Test Details


Methodology

See individual assays